"10.1371_journal.pone.0039132","plos one","2012-06-18T00:00:00Z","Nicolas Dzamko; Francisco Inesta-Vaquera; Jiazhen Zhang; Chengsong Xie; Huaibin Cai; Simon Arthur; Li Tan; Hwanguen Choi; Nathanael Gray; Philip Cohen; Patrick Pedrioli; Kristopher Clark; Dario R Alessi","MRC Protein Phosphorylation Unit, College of Life Sciences, University of Dundee, Dow Street, Dundee, Scotland; Transgenic Section, Laboratory of Neurogenetics, National Institute of Aging, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, United States of America; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America; Department of Biological Chemistry and Molecular Pharmacology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America; Scottish Institute of Life Sciences, College of Life Sciences, University of Dundee, Dow Street, Dundee Scotland","Conceived and designed the experiments: ND FIV KC SA PC DRA. Performed the experiments: ND FIV JZ KC. Analyzed the data: ND FIV JZ KC SA PP DRA. Contributed reagents/materials/analysis tools: CZ HC LT HC NG. Wrote the paper: ND DRA.","Our research Unit receives general funding from the pharmaceutical companies supporting the Division of Signal Transduction Therapy Unit (AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Janssen Pharmaceutica; Merck KgaA and Pfizer) for financial support. I can also confirm that this does not alter our adherence to all the PLoS ONE policies on sharing data and materials.","2012","06","Nicolas Dzamko","ND",13,TRUE,6,4,7,2,TRUE,TRUE,TRUE,1,"4",FALSE
